ColoCare Study - Colorectal Cancer Cohort

Part of paid clinical trials in Los Angeles, California.

Sponsor
University of Utah
Study ID
NCT02328677
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 89 Years
Healthy Volunteers
Not accepted

Study Details

ColoCare is an international prospective cohort study of stage I-IV colorectal cancer patients (ICD-10 C18-C20).

Key Dates

Start date
Mar 31, 2007
Status verified
Jun 2025
Primary completion
Oct 31, 2030
Completion
Oct 31, 2030

Study Design

Enrollment
5,000 participants (estimated)

Arms

  • Arm: ColoCare FHCC
    Active patient recruitment, follow-up, and multiple specimen collection Repeated sampling at multiple timepoints Longitudinal assessment of biomarkers and health behaviors Recruitment Status August 31, 2023: n=741
  • Arm: ColoCare Moffitt (affiliated cohort)
    Active patient recruitment, follow-up, and multiple specimen collection Repeated sampling at multiple timepoints Longitudinal assessment of biomarkers and health behaviors Recruitment Status August 31, 2023: n=1,043
  • Arm: University Hospital Heidelberg
    Active patient recruitment, follow-up, and multiple specimen collection Repeated sampling at multiple timepoints Longitudinal assessment of biomarkers and health behaviors Recruitment Status August 31, 2023: n=773
  • Arm: ColoCare Huntsman Cancer Institute
    Active patient recruitment, follow-up, and multiple specimen collection Repeated sampling at multiple timepoints Longitudinal assessment of biomarkers and health behaviors Recruitment Status August 31, 2023: n=514
  • Arm: Cedars-Sinai Medical Center
    Active patient recruitment, follow-up, and multiple specimen collection Repeated sampling at multiple timepoints Longitudinal assessment of biomarkers and health behaviors Recruitment Status August 31, 2023: n=291
  • Arm: Washington University School of Medicine in St. Louis
    Active patient recruitment, follow-up, and multiple specimen collection Repeated sampling at multiple timepoints Longitudinal assessment of biomarkers and health behaviors Recruitment Status August 31, 2023: n=278
  • Arm: University of Tennessee
    Active patient recruitment, follow-up, and multiple specimen collection Repeated sampling at multiple timepoints Longitudinal assessment of biomarkers and health behaviors Recruitment Status August 31, 2023: n=253

Primary Outcome Measure

Disease-free and overall survival [ Time Frame: up to 10 years ]

Central Contacts

Locations (6)

FacilityCityStateZIPSite coordinators
Cedars-Sinai Medical CenterLos AngelesCalifornia90048
Jane Figueiredo, PhD
[email protected]
Lee H. Moffitt Cancer CenterTampaFlorida12902
Erin Siegel, PhD
[email protected]
Washington University School of MedicineSt LouisMissouri63112
Adetunji T Toriola, MD, PhD
[email protected]
University of TennesseeKnoxvilleTennessee37996
David Shibata, MD
[email protected]
Huntsman Cancer InstituteSalt Lake CityUtah84112
Cornelia Ulrich, MS, PhD
[email protected]
FHCRCSeattleWashington98109-1024
Christopher Li, MD, PhD
[email protected]
William Grady, MD, PhD
[email protected]

Find similar trials in Los Angeles, CA

By condition
Colorectal cancer
By specialty
OncologyGI oncology
By research site
Cedars-Sinai Medical Center· Los Angeles, CALee H. Moffitt Cancer Center· Tampa, FLWashington University School of Medicine· St Louis, MOUniversity of Tennessee· Knoxville, TNHuntsman Cancer Institute· Salt Lake City, UTFHCRC· Seattle, WA

Related Studies